VGM & Associates Announces Dave Lyman as Executive Vice President

Published in Member Communities on April 22, 2024

Dave Lyman

VGM & Associates is excited to announce that Dave Lyman, BA, RRT-SDS has been promoted to Executive Vice President (EVP). In his new role, Dave will focus on leading and growing VGM membership communities, as well as leading VGM’s sales, business development, contracting, and marketing teams.

Dave has more than 25 years of experience in the durable medical equipment industry. Dave started his career as a respiratory therapist (RT) at the Cleveland Clinic. Dave most recently served as SVP, Sales for VGM & Associates, where he led VGM’s member success team. He also serves on multiple committees dedicated to patient outcomes and care, including co-chair for the education committee for OAMES and AAHomecare Respiratory focus group.

"For the past 10 years, I’ve had the privilege of working closely with VGM members, vendor partners, and fellow employee owners to forge meaningful relationships and establish successful business partnerships,” says Dave. “I look forward to continue growing and retaining our membership groups, as well as keeping VGM & Associates at the forefront of the industry.”

Dave’s experience as an RT, coupled with his knowledge of clinical operations, billing, management, and sales in the DME industry, has been instrumental in overseeing several of VGM’s programs.

“We are beyond excited to have Dave appointed to this new role at VGM,” says Lindy Tentinger, President, VGM & Associates. “Dave has consistently demonstrated the ability to be an engaging business and sales leader who builds important relationships with our members and vendor partners while also meeting our business objectives. His skillset and experience is critical to enhancing the post-acute homecare industry as a whole.” 


TAGS

  1. dmepos
  2. hme
  3. leadership
  4. vgm

From Our Experts

Medicare Telehealth Flexibilities Extended for CRT Providers thumbnail Medicare Telehealth Flexibilities Extended for CRT Providers Learn how the new Medicare telehealth extension impacts CRT providers. U.S. Rehab's Dan Fedor explains why remote care access remains vital through 2027. Why CRT Providers Are Exploring Home Accessibility in 2026 thumbnail Why CRT Providers Are Exploring Home Accessibility in 2026 Home accessibility is emerging as a major growth path for CRT providers. Explore the trend and learn why strategic, low-risk steps matter. Log in for the full article. Doing More With Less: Home Access in 2026 thumbnail Doing More With Less: Home Access in 2026 Discover how home access remodelers can do more with less using outsourced labor, virtual assessments, standardized materials, and templated scopes. Building a Skilled Home Access Workforce Through Training thumbnail Building a Skilled Home Access Workforce Through Training Discover why training, certifications, and cross-training are essential for home access professionals. VGM Live at Home Spotlight: Chris Moore & the Power of “Age Out Loud” thumbnail VGM Live at Home Spotlight: Chris Moore & the Power of “Age Out Loud” VGM Live at Home spotlights Chris Moore, whose book Age Out Loud and passion for CAPS training inspire professionals to help more people age safely at home. A Note from the President: VGM is Evolving For You thumbnail A Note from the President: VGM is Evolving For You VGM is evolving with purpose by investing in advocacy, technology, and services to support HME providers through industry change and ensure long-term viability. Introducing the F&P Nova Nasal in the United States thumbnail Introducing the F&P Nova Nasal in the United States Fisher and Paykel Healthcare has announced the launch of their newest nasal PAP mask, F&P Nova Nasal, to the United States, for the treatment of obstructive sleep apnea. Introducing the F&P Nova Nasal in the United States thumbnail Introducing the F&P Nova Nasal in the United States Fisher and Paykel Healthcare has announced the launch of their newest nasal PAP mask, F&P Nova Nasal, to the United States, for the treatment of obstructive sleep apnea.